Use of Comparative Effectiveness Research in Drug Coverage and Pricing Decisions: A Six-Country Comparison

Examines the review processes of comparative effectiveness research in drug coverage and pricing in Denmark, the United Kingdom, France, Germany, the Netherlands, and Sweden. Considers policy implications for the United States, including limitations.